Search
Innate Pharma SA
IPHAAdd to Watchlist
2.180USD
-0.355-14.00%
Close 08-14 16:00（ET）Quotes delayed by 15 min
202.21MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated:Analyst Rating
Based on
4
analysts
Buy
Current Rating
7.097
Target Price
+225.55%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Innate Pharma SA
IPHA
4
Beigene Ltd
ONC
28
argenx SE
ARGX
28
Ionis Pharmaceuticals Inc
IONS
25
IQVIA Holdings Inc
IQV
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
FAQs
What is Innate Pharma SA's price target?
Analysts forecast that Innate Pharma SA's price target is USD 6.00, with the highest forecast at USD 11.00 and the lowest forecast at USD 2.00.
What is the analyst rating for Innate Pharma SA?
Based on the ratings of Innate Pharma SA's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.